Another good news for Caplin point, Caplin sterile ltd ( Subsidiary) has received final approval by the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Norepinephrine Bitartrate Injection USP.
The final approval was received on 20th September 2023
Disc : Invested. Not SEBI registered
| Subscribe To Our Free Newsletter |
